Gefitinib
NDC 67184-0531, Gefitinib, tablet, coated, from Qilu Pharmaceutical Co., Ltd..
- Product NDC
- 67184-0531
- Status
- Listed
- Labeler
- Qilu Pharmaceutical Co., Ltd.
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA211591
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0531 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- GEFITINIB250 mg/1
Pharmacologic classes
Kinase Inhibitor [EPC]; Protein Kinase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67184-0531-1 | 67184053101 | 30 TABLET, COATED in 1 BOTTLE (67184-0531-1) |
| 67184-0531-2 | 67184053102 | 500 TABLET, COATED in 1 BOTTLE (67184-0531-2) |
| 67184-0531-3 | 67184053103 | 3 BLISTER PACK in 1 CARTON (67184-0531-3) / 10 TABLET, COATED in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/0afc12dd-12f8-4def-9027-f38412a862b9
Use it
Look up 67184-0531 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67184-0531 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67184-0531. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.